ArticlemHealth2021
Apps for individuals diagnosed with breast cancer: a preliminary assessment of the content and quality of commercially available apps in Spanish.
Article in mHealth, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundmany apps are directly related to health issues. Recent studies show that apps are widely accepted by the population and contribute to the modernization of the healthcare system. However, before recommendation, their contents and quality should be assessed, as well as the behavioral change techniques they include. In Spain, no study has been found to determine which apps are aimed at addressing any aspect of breast cancer. The objective of this study was to identify and describe the contents and analyze the quality and behavior change strategies of the free applications available in the online stores of Android and Apple whose main purpose is related to some aspect of breast cancer.
methodsSearches were conducted in the Apple App and Google Play stores in Spain, between October 2018 and February 2019, using an Apple iPad Pro and a Samsung Galaxy Tab A6. The Spanish search terms used were: "cáncer de mama" [breast cancer], "cáncer de pecho" [breast cancer], "cáncer de seno" [breast cancer], "tumor de mama" [breast tumor], "tumor de pecho" [breast tumor], "tumor de seno" [breast tumor], "neoplasia de mama" [breast neoplasm], "neoplasia de pecho" [breast neoplasm], and "neoplasia de seno" [breast neoplasm]. After screening, contents related to breast cancer, quality, and behavioral change were assessed.
resultsThe contents of the 6 selected apps were related to breast self-examination and to the signs and symptoms that may warn the woman of the presence of a breast tumor. The MARS objective and subjective quality scores were 4.11 (SD =0.59) and 3.07 (SD =0.91), respectively. The mean number of BCTs included in the apps was 2.83 (SD =3.040). The app with the highest number of BCTs was APP1, with a total of 9 techniques.
conclusionsFew free apps are specifically designed for breast cancer in Spanish. Their content and quality, as well as the number of BCTs they include, should be improved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.